Related Experiment Video
Updated: Apr 19, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Loss of PRDM11 promotes MYC-driven lymphomagenesis
Cathrine Kolster Fog1, Fazila Asmar2, Christophe Côme1
1Biotech Research and Innovation Centre and Centre for Epigenetics, University of Copenhagen, Copenhagen, Denmark;
Abstract:
The PR-domain (PRDM) family of genes encodes transcriptional regulators, several of which are deregulated in cancer. By using a functional screening approach, we sought to identify novel tumor suppressors among the PRDMs. Here we demonstrate oncogenic collaboration between depletion of the previously uncharacterized PR-domain family member Prdm11 and overexpression of MYC. Overexpression of PRDM11 inhibits proliferation and induces apoptosis. Prdm11 knockout mice are viable, and loss of Prdm11 accelerates MYC-driven lymphomagenesis in the Eµ-Myc mouse model. Moreover, we show that patients with PRDM11-deficient diffuse large B-cell lymphomas (DLBCLs) have poorer overall survival and belong to the nongerminal center B-cell-like subtype. Mechanistically, genome-wide mapping of PRDM11 binding sites coupled with transcriptome sequencing in human DLBCL cells evidenced that PRDM11 associates with transcriptional start sites of target genes and regulates important oncogenes such as FOS and JUN. Hence, we characterize PRDM11 as a putative novel tumor suppressor that controls the expression of key oncogenes, and we add new mechanistic insight into B-cell lymphomagenesis.
Insights
The previously uncharacterized PRDM11 gene acts as a tumor suppressor by regulating oncogenes. Loss of PRDM11 accelerates MYC-driven lymphoma, impacting patient survival in diffuse large B-cell lymphomas.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The PR-domain (PRDM) gene family encodes transcriptional regulators implicated in cancer.
- Functional screening is a valuable approach for identifying novel tumor suppressors.
- Understanding PRDM gene deregulation is crucial for cancer therapy development.
Purpose of the Study:
- To identify novel tumor suppressors within the PRDM gene family.
- To investigate the role of the uncharacterized PRDM family member, Prdm11, in cancer.
- To elucidate the mechanistic basis of Prdm11's function in lymphomagenesis.
Main Methods:
- Functional screening approach to identify novel tumor suppressors.
- In vivo studies using Prdm11 knockout mice and the Eµ-Myc mouse model.
- Analysis of PRDM11-deficient diffuse large B-cell lymphomas (DLBCLs) patient data.
- Genome-wide mapping of PRDM11 binding sites and transcriptome sequencing.
Main Results:
- Depletion of Prdm11 collaborates with MYC overexpression, promoting oncogenesis.
- Overexpression of PRDM11 inhibits proliferation and induces apoptosis.
- Loss of Prdm11 accelerates MYC-driven lymphomagenesis in mice.
- PRDM11-deficient DLBCL patients exhibit poorer survival and belong to the non-germinal center B-cell-like subtype.
- PRDM11 binds to transcriptional start sites and regulates oncogenes like FOS and JUN.
Conclusions:
- PRDM11 is characterized as a putative novel tumor suppressor.
- PRDM11 controls the expression of key oncogenes, including FOS and JUN.
- This study provides new mechanistic insights into B-cell lymphomagenesis and highlights PRDM11 as a potential therapeutic target.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

